Ruste, Leonora L.
HRN: 06-70-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2024
METRONIDAZOLE 500MG (TAB)
10/10/2024
10/17/2024
IVT
500MG
Q 8 HRS
TMSAF; FDU
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes